What is Celligent Diagnostics?
Celligent Diagnostics is a specialized provider of innovative pathology services, catering to the diverse diagnostic needs of the medical community. The company's core offerings encompass histology, women's health diagnostics, and ancillary testing, all meticulously designed to elevate patient care through the delivery of precise and timely results. Recognizing the importance of accessibility, Celligent Diagnostics offers a user-friendly web portal for ancillary testing orders, streamlining the process for clients and healthcare facilities. Their commitment to advancing healthcare outcomes is driven by a foundation of cutting-edge pathology solutions.
How much funding has Celligent Diagnostics raised?
Celligent Diagnostics has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Celligent Diagnostics?
The substantial late-stage funding Celligent Diagnostics has attracted signals a strategic pivot towards significant scaling and market penetration. This capital infusion is likely to fuel the expansion of its service offerings, enhance technological infrastructure, and broaden its geographical reach. The company is poised to solidify its leadership in the pathology diagnostics market, potentially exploring strategic partnerships or acquisitions to accelerate growth and further innovate within the healthcare ecosystem.
See full Celligent Diagnostics company page
